The Transplantation & Cellular Therapy (TCT) 2021 Meeting was held virtually this year due to the ongoing COVID-19 pandemic and highlighted recent advances in the field of transplantation and cellular therapies.
View all videosTCT 2021
Published by @VJHemOnc https://www.vjhemonc.com/video/lisaxt2d-2g-sierra-trial-updates-apamistamab-in-aml/
A simplified comorbidity index to predict mortality in allo-HCT recipients, w/ @RShouval of @sloan_kettering: http://ow.ly/8O4W50DHy9a
#TCTM21 @ASTCT #HemOnc #BMTsm
Research projects within the EN-ACTI2NG program: DNA aptamers and #CART therapies.
Hear from Hisse M. van Santen (@CBMSO_CSIC_UAM): http://ow.ly/26fz50DHy4K
#CART21 @TheEBMT @EHA_Hematology #HemOnc #ImmunoOnc #tcellrx #CellularTherapy #Immunotherapy
TCT 2021
The Transplantation & Cellular Therapy (TCT) 2021 Meeting was held virtually this year due to the ongoing COVID-19 pandemic and highlighted recent advances in the field of transplantation and cellular therapies.
View all videosPublished by @VJHemOnc https://www.vjhemonc.com/video/lisaxt2d-2g-sierra-trial-updates-apamistamab-in-aml/
A simplified comorbidity index to predict mortality in allo-HCT recipients, w/ @RShouval of @sloan_kettering: http://ow.ly/8O4W50DHy9a
#TCTM21 @ASTCT #HemOnc #BMTsm
Research projects within the EN-ACTI2NG program: DNA aptamers and #CART therapies.
Hear from Hisse M. van Santen (@CBMSO_CSIC_UAM): http://ow.ly/26fz50DHy4K
#CART21 @TheEBMT @EHA_Hematology #HemOnc #ImmunoOnc #tcellrx #CellularTherapy #Immunotherapy
